Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended June 30, 2024.

Glenmark Life Sciences has posted net profit of Rs. 111.483 crores for the period ended June 30, 2024 as against net profit of Rs. 97.937 crores for the period ended March 31, 2024. The company posted net profit of Rs.135.450 crores for the period ended June 30, 2023.

Glenmark Life Sciences has reported total income of Rs. 594.109 crores during the period ended June 30, 2024 as compared to Rs. 539.728 crores during the period ended March 31, 2024. The company reported total income of Rs.580.301 crores during the period ended June 30, 2023.